Evidence map›Paper›PMID 35497760›Full record

ArticleRSC advances2020

Effects of a natural PTP1B inhibitor from

Shuju Guo, Lijun Wang, Dong Chen, Bo Jiang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. The Ocean's Pharmacy: Health Discoveries in Marine Algae.Molecules (Basel, Switzerland) · 2024
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Shuju GuoKey Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences 7 Nanhai Road Qingdao 266071 China jiangbo@qdio.ac.cn.ORCID https://orcid.org/0000-0002-2377-7870
Lijun WangKey Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences 7 Nanhai Road Qingdao 266071 China jiangbo@qdio.ac.cn.
Dong ChenKey Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China Yushan Road Qingdao 266003 P. R. China.
Bo JiangKey Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences 7 Nanhai Road Qingdao 266071 China jiangbo@qdio.ac.cn.ORCID https://orcid.org/0000-0001-6889-6841
Chinese Academy of Sciences · CNMinistry of Education · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PTP1B is a key negative regulator of insulin signaling transduction, and the inhibition of PTP1B has emerged as a potential therapeutic strategy to treat T2DM. 3,4-Dibromo-5-(2-bromo-6-(ethoxymethyl)-3,4-dihydroxybenzyl)benzene-1,2-diol (BPN), a natural bromophenol isolated from marine red alga

Identifiers

PMID35497760
PMCPMC9048848
OpenAlexW3002355927

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.